Paths Links People

Paths Links People

Thonigala Inscriptions are of the 2nd Century BC and carved on Rock. information courtesy;Internet

Thonigala Inscriptions are of the 2nd Century BC and carved on Rock. information courtesy;Internet
Tonigala. (a.) Parumaka Abaya puta parumaka Tisaha wapi acagirika Tisa pawatahi agata anagata catudisa sagasa dine. Dewana pi maharaja Gamini Abaye niyate acanagaraka ca [tawi] rikiya nagaraka ca. Parumaka Abaya puta parumaka Tisa niyata pite raj aha agata anagata catudisa sagasa

History; Path to future

History; Path to future
Reading Future through History, Nagala mountain and the Stupa of the Nagala Kanda Rajamaha Viharaya, Nikaweva, Polpithigama, Kurunegala District.

yesterdays kingdoms enhanced people's today

yesterdays kingdoms enhanced people's today
let us view today through past ...........Kingdom of Yapahuwa - 13th Century

Wednesday, October 26, 2016

How does the new drug control act affects others?

Above is a question that i have in my mind that require an answer.

first and fore most, let me tell you that i too think that there is no harm in having such a system that supports the customers, patients in particular.

Yet, 

Does this act / law / practices protects the drug manufacturer/s?

How does it affect each and every singular party that are in the health sector dealing with drugs / Medicines?

According to the ideas of one of the Pharmacists i spoke to today, in order to know whether the new practice / act affects / affected them / their businesses ?

one of them said that it won't affect them that much but it affects the companies 

i assume that what he meant by 'companies' is the suppliers , drug importing companies / manufacturers.   

And i stepped into about three pharmacies to buy panadol , one of the famous brand that is generally available in any of the shops in the ordinary market (Local Market) and in small shops, boutiques without any 'out of stock' issues.  only one of the pharmacies had panadol, i purchased couple of panadol for three rupees. That is the newest price. 

Earlier, to buy two panadols the customer needed Rs. 6 / = and now to buy two of them the customer needs only a three rupees that is a relief no doubt but if you analyze it from the company point of view, the rupees that the company is loosing due to price reduction  after selling two panadols is three rupees. 

My question is how does the company manage to cope with the situation and is there a way that they can internally survive without trying any other solutions, stopping supplying drugs to the shops / pharmacies, for example?. 

And is there a way that the drug manufactures can easily buy the medicinal stuff that they need for their drug manufacturing processes for a lower price and supply what the local market needs without embracing any headaches , aches and pains? any aches and pains directly affect their 'profit'? 

Can the government supply what they require for drug manufacturing for a reasonable price? and everything they need?

if the government drug manufacturing agency , factory has the capacity , ability to supply every singular drug need of the citizens , the pharmacies that request depending on what they sell?

what are the ways they can access the government drug manufactures / relevant authorities to get the required support?

if government has a particular , certain procedure that they follow in order to import drugs / medicines that require to cater the drug needs of the local citizens , can they provide the lists of the drug companies they deal with?  

And can we know , how does the government deal with the drug exporting companies outside to country and under what conditions and criteria?  

what is the nature of the agreements made between the drug suppliers , if there are any as such?  

what is the proceedure that the government follow currently to check the 'quality of the drug?

according to what one of the pharmacists reveled, there is a difference between the drugs that the customer purchase from the 'original drug innovator', company that owns the original patent to deal with , manufacture particular drug / s and the drugs that the customer purchase from a company that does not belong to that drug manufacturing category. 

According to what he said because of that difference between the original drug and the copied drug, the patient will have to intake more dose than the dose he / she was prescribed depending on the illness / status. 

i.e if the patient was prescribed to take 500mg of a particular drug, and if that particular original drug is not available in the market for example, and if the patient trying another copied drug, instead of the original that is available in the market supplied buy any of the companies of the world, to get expected result (cure / control) the same patient / another will have to purchase 1500mg because of the way it reacts / works within the human body. i.e 'side affects' may leads to other illnesses.?

what is the solution that the patients have to cope or deal with such situations? 


this essay is to be continued .................

   







No comments:

Post a Comment